Cite
HARVARD Citation
Wahby, K. et al. (2017). Assessment of an Extended Interval Fondaparinux Dosing Regimen for Venous Thromboembolism Prophylaxis in Critically Ill Patients with Severe Renal Dysfunction Using Antifactor Xa Levels. Pharmacotherapy. 37 (10), pp. 1241-1248. [Online].